Treatment with posterior capsular release, botulinum toxin injection, hamstring tenotomy, and peroneal nerve decompression improves flexion contracture after total knee arthroplasty: minimum 2-year follow-up.
Aged
Arthroplasty, Replacement, Knee
/ adverse effects
Botulinum Toxins, Type A
/ administration & dosage
Contracture
/ diagnostic imaging
Decompression, Surgical
/ methods
Female
Follow-Up Studies
Hamstring Muscles
/ surgery
Humans
Injections
Joint Capsule Release
Knee Joint
/ diagnostic imaging
Male
Middle Aged
Peroneal Nerve
/ surgery
Postoperative Complications
/ surgery
Radiography
Range of Motion, Articular
Retrospective Studies
Tenotomy
/ methods
Treatment Outcome
Botulinum toxin
Knee flexion contracture
Manipulation under anesthesia
Posterior capsular release
Total knee arthroplasty
Journal
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
23
10
2019
accepted:
11
03
2020
pubmed:
24
4
2020
medline:
29
12
2020
entrez:
24
4
2020
Statut:
ppublish
Résumé
No definite treatment option with reasonable outcome has been presented for old and refractory flexion contracture after total knee arthroplasty (TKA). We describe a surgical technique for 21 refractory cases of knee flexion contracture, including 12 patients with history of failed manipulation under anesthesia (MUA). Retrospective review was conducted for procedures performed by a single surgeon between 2005 and 2016. Twenty-one knees (19 patients) with knee flexion contracture after primary TKA were treated with all the following procedures: posterior capsular release, hamstring tenotomy, prophylactic peroneal nerve decompression, and botulinum toxin type A injections. Twelve of the 21 knees had at least 1 prior unsuccessful MUA before this soft-tissue release procedure. Mean age at intervention was 60 years (range 46-78 years). Mean preoperative knee range of motion (ROM) was - 27° extension (range - 20° to - 40°) to 100° flexion (range 90°-115°). All radiographs were evaluated for proper component sizing and signs of loosening. Full extension was achieved immediately after surgery in all patients. Only one knee required repeat botulinum toxin type A injection. All patients had full extension at mean follow-up of 31 months (range 24-49 months). No significant change was observed in knee flexion after the procedure (n.s.). Significant improvement was noted in the postoperative Knee Society Score (KSS) (mean 80, range 70-90) when compared with preoperative KSS (mean 45, range 25-65) (p = 0.008). The proposed surgical technique is efficacious in treating patients with refractory knee flexion contracture following TKA to gain and maintain full extension at minimum 2-year follow-up. IV, retrospective case series.
Identifiants
pubmed: 32322950
doi: 10.1007/s00167-020-05939-0
pii: 10.1007/s00167-020-05939-0
doi:
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM